INCB28060 Dihydrochloride

INCB28060 Dihydrochloride Basic information
Product Name:INCB28060 Dihydrochloride
Synonyms:2-Fluoro-N-methyl-4-[7-[(quinolin-6-yl)methyl]imidazo[1,2-b]-[1,2,4]triazin-2-yl]benzamide Dihydrochloride;INCB28060 2HCl;INCB28060 Dihydrochloride;Capmatinib 2HCl;INC-280 2HCl;Capmatinib Dihydrochloride;Benzamide, 2-fluoro-N-methyl-4-[7-(6-quinolinylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]-, hydrochloride (1:2);Capmatinib,Apoptosis,c-Met/HGFR,INC 280,H441,INCB28060,INC280,orally active,Capmatinib 2HCl,INCB-28060,SNU-5,INC-280,Inhibitor,S114,INCB 28060,inhibit,U-87MG,ATP competitive,Balb/c nu/nu mice
CAS:1197376-85-4
MF:C23H18ClFN6O
MW:448.89
EINECS:695-736-8
Product Categories:API;API
Mol File:1197376-85-4.mol
INCB28060 Dihydrochloride Structure
INCB28060 Dihydrochloride Chemical Properties
Safety Information
MSDS Information
INCB28060 Dihydrochloride Usage And Synthesis
DescriptionINCB28060 Dihydrochloride is a novel, ATP-competitive inhibitor of c-MET kinase with an IC50 with 0.13 nM.
UsesINCB28060 dihydrochloride exhibits picomolar enzymatic potency and is highly specific for c-MET with more than 10, 000-fold selectivity over a large panel of human kinases. This inhibitor potently blocks c-MET phosphorylation and activation of its key downstream effectors in c-MET-dependent tumor cell lines. As a result, INCB 28060 potently inhibits c-MET-dependent tumor cell proliferation and migration and effectively induces apoptosis in vitro.
INCB28060 Dihydrochloride Preparation Products And Raw materials
Vandetanib Olaparib Nintedanib Ethanesulfonate Salt AZD-9291 Lorlatinib (PF-06463922) Afatinib (BIBW 2992) Crizotinib Cediranib Maleate Cabozantinib Malate Dacomitinib (PF299804) BIBW2992 DiMaleate Poziotinib (HM781-36B) Neratinib Regorafenib Trametinib Dabrafenib lenvatinib Mesylate Capmatinib

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.